Synopsis

Source of validity: Scientific
Rating (out of 5): 2

N-phenylacetyl-L-Prolylglycine ethyl ester, commonly known as Noopept, is a synthetic nootropic compound. Its relevance to the "dopamine body system" comes primarily from preclinical research suggesting possible neuroprotective and cognitive-enhancing effects. Some animal studies indicate that Noopept may increase the expression of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), both of which are involved in neuronal health and plasticity, and may interact with neurotransmitter systems, including dopamine. However, direct evidence of Noopept specifically supporting or modulating the dopaminergic system in humans is limited. There is some preclinical evidence that Noopept can modulate dopamine receptor density and may influence dopamine metabolism, but these findings have not been robustly demonstrated in human trials. Most human data are anecdotal or come from small, non-rigorous studies, with claims of enhanced cognition, focus, or mood that could be related to dopamine but are not directly measured or confirmed. In summary, there is some scientific basis for the potential interaction of Noopept with the dopaminergic system, but significant gaps remain, and robust clinical validation is lacking. Therefore, the evidence supporting its use for "dopamine body system" support is modest and preliminary, meriting a low-to-moderate rating.

More about N-phenylacetyl-L-Prolylglycine ethyl ester
More about Dopamine

Other ingredients that support Dopamine

Other body systems supported by N-phenylacetyl-L-Prolylglycine ethyl ester

Products containing N-phenylacetyl-L-Prolylglycine ethyl ester